• Company
• GI Innovation registers patent in US for its GI-101/GI-102
• by Nho, Byung Chul Nov 16, 2023 05:46am

• Policy
• Abbvie’s Skyrizi is approved for Crohn's disease in Korea
• by Lee, Hye-Kyung Nov 16, 2023 05:46am

• Company
• Poteligel can be prescribed at hospitals
• by Eo, Yun-Ho Nov 15, 2023 05:39am

• Company
• Korean bio companies intent on developing new AD drugs
• by Son, Hyung-Min Nov 15, 2023 05:39am

• Policy
• Chinese immunotherapy tislelizumab to soon arrive in KOR
• by Lee, Hye-Kyung Nov 15, 2023 05:39am

• Company
• Will the new ADC breast cancer drug Trodelvy be reimb?
• by Eo, Yun-Ho Nov 15, 2023 05:39am

• Policy
• Drug price lawsuit recovery & refund, effective on the 20th
• by Lee, Jeong-Hwan Nov 15, 2023 05:39am

• Policy
• Enforcement rules for the recovery of drug price
• by Lee, Jeong-Hwan Nov 14, 2023 05:49am

• Company
• Market for montelukast revive…overcomes impurity issue
• by Kim, Jin-Gu Nov 14, 2023 05:49am

• Policy
• Discussions on external drug price referencing reevals begin
• by Lee, Tak-Sun Nov 14, 2023 05:49am